R&D Pipeline

ENYO Pharma’s platform has already nurtured key programs with a phase I clinical trial initiated for a chronic hepatitis B indication and toxicology testing for 3 classes of molecules against Flu.

enyo-pipeline-header
enyo-pipeline-hepatitisb
enyo-pipeline-influenza
enyo-pipeline-early-projects
enyo-pipeline-footer